Xiaoyan Ke
Overview
Explore the profile of Xiaoyan Ke including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
179
Citations
2072
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li D, Liu R, Fu Z, Yang F, Ma L, Guo Y, et al.
Front Immunol
. 2025 Mar;
16:1532460.
PMID: 40078989
Autologous stem cell transplantation (ASCT) and chimeric antigen receptor T-cells (CAR-T) have been used as consolidation therapies for patients with refractory/relapsed B cell non-Hodgkin's lymphoma (R/R B-NHL) in remission after...
2.
Long D, Yang T, Chen J, Zhang J, Dai Y, Chen L, et al.
Child Adolesc Psychiatry Ment Health
. 2025 Mar;
19(1):18.
PMID: 40045319
Background: Motor disturbance, as a related symptom of autism spectrum disorders (ASD), has not received the attention it deserves. We aimed to investigate the different degrees of motor developmental delay...
3.
Ma L, Dou Y, Liu R, Xu T, Yang F, Zheng P, et al.
Cancer Rep (Hoboken)
. 2025 Jan;
8(1):e70083.
PMID: 39871823
Objective: Currently, chimeric antigen receptor T-cell (CART) therapy represents a highly effective approach for relapsed/refractory B-cell lymphomas. However, it also carries treatment-related risks. Limited data are available on the risks...
4.
Zheng P, Xu T, Zuo X, Ke X, Hu K
EJHaem
. 2025 Jan;
6(1):e1078.
PMID: 39866943
Here, we report a case of Epstein-Barr virus-positive central nervous system-post-transplant lymphoproliferative disorder (CNS-PTLD) patient who failed to achieve complete metabolic remission (CMR) after successively trying a methotrexate-based regimen combined...
5.
Qian L, Ding N, Fang H, Xiao T, Sun B, Gao H, et al.
BMC Psychiatry
. 2025 Jan;
25(1):58.
PMID: 39833750
Background: Pragmatic language refers to using spoken language to convey messages effectively across diverse social communication contexts. However, minimal longitudinal research has focused on defining early predictors of pragmatic development...
6.
Kan S, Bai H, Liu H, Cui J, Ke X, Zhang H, et al.
Leuk Res
. 2025 Jan;
149:107633.
PMID: 39799811
Background: Treating relapsed or refractory classical Hodgkin lymphoma (R/R cHL) remains challenging. This report extends the three-year follow-up period for the phase Ⅱ YH-S001-04 trial, expanding upon the initial 15.8-month...
7.
Wang Y, Zhu Z, Wang Y, Li M, Ma X, Huang K, et al.
Quant Imaging Med Surg
. 2024 Dec;
14(12):8347-8360.
PMID: 39698690
Background: Autism spectrum disorder (ASD) often presents with atypical visual processing, prompting investigation into its connection with retinal features. This study aimed to (I) compare intraretinal layer thickness in the...
8.
Han X, He Y, Wang Y, Hu W, Chu C, Huang L, et al.
Adv Sci (Weinh)
. 2024 Nov;
12(2):e2406849.
PMID: 39556706
Autism spectrum disorder (ASD), which is caused by heterogeneous genetic and environmental factors, is characterized by diverse clinical phenotypes linked to distinct pathological mechanisms. ASD individuals with a shared clinical...
9.
Wang J, Tian L, Zhang W, Tang S, Zhao W, Guo Y, et al.
J Blood Med
. 2024 Sep;
15:407-419.
PMID: 39279878
Background: The application of rituximab has significantly enhanced the overall survival rates in patients with diffuse large B-cell lymphoma (DLBCL). Regrettably, a significant number of patients still progress to relapse/refractory...
10.
Li M, Wang Y, Gao H, Xia Z, Zeng C, Huang K, et al.
Autism Res
. 2024 Jul;
17(8):1520-1533.
PMID: 39075780
Autism spectrum disorder (ASD) is a widely recognized neurodevelopmental disorder, yet the identification of reliable imaging biomarkers for its early diagnosis remains a challenge. Considering the specific manifestations of ASD...